Vaxcyte Inc.

NASDAQ: PCVX · Real-Time Price · USD
32.66
1.23 (3.91%)
At close: Aug 15, 2025, 3:59 PM
32.70
0.12%
After-hours: Aug 15, 2025, 04:54 PM EDT

Vaxcyte Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-547.5M -509.63M -463.93M -507.65M -497.19M -436.82M -402.27M -299.51M -264.77M -244.96M -223.49M -174M -142.7M -117.84M -100.08M -92.25M -86.65M -83.3M
Depreciation & Amortization
19.14M 17.63M 15.85M 14.01M 12M 10.92M 10.17M 9.52M 9.4M 9.17M 9.2M 8.1M 6.6M 5.3M 3.46M 2.58M 2.06M 1.55M
Stock-Based Compensation
113.18M 97.81M 84.82M 73.8M 65.75M 56.74M 48.76M 42.42M 35.85M 29.2M 23.65M 19.8M 16.09M 12.96M 10.73M 9.51M 8.41M 6.93M
Other Working Capital
-12.89M -30.33M -17.94M 47.44M 59.83M 57.14M 70.09M 31.74M 10.4M 8.5M 9.84M 7.23M -12.28M -21.5M -24.54M -16.36M -11.16M 9.02M
Other Non-Cash Items
-71.1M -35.01M -16.33M -4.95M -6.96M -8.87M -22.01M -25.59M -11.25M 893K 7.3M 1.05M 1.75M 1.77M 1.5M 944K 499K 452K
Deferred Income Tax
n/a n/a n/a -12.77M -12.77M -12.77M -12.77M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
26.73M -30.58M -54.9M -14.35M -9.57M 715K 81.32M 39.96M 16.57M 15.12M 12.74M -11.42M -28.08M -38.08M -37.01M -1.85M 9.98M 28.17M
Operating Cash Flow
-459.55M -459.78M -452.63M -470.04M -466.88M -408.22M -296.79M -233.2M -214.2M -190.59M -170.6M -156.47M -146.34M -135.89M -121.39M -81.07M -65.71M -46.2M
Capital Expenditures
-75.34M -140.23M -125.55M -152.59M -121.85M -74.34M -67.88M -11.96M -5.46M -8.54M -5.85M -6.08M -6.96M -8.23M -6.55M -5.89M -4.21M -2.05M
Cash Acquisitions
n/a n/a n/a -43.14K -72.76K 262.94K 705.43K 783.38K 777.45K 414.64K -20.85K -29.65K 5.9K 33K 26K n/a n/a n/a
Purchase of Investments
-2.71B -2.71B -3.09B -2.48B -1.45B -1.53B -1.33B -1.2B -1.01B -579.55M -102.75M -72.52M -121.68M -171.17M -336.34M -295.28M -228.53M -172.15M
Sales Maturities Of Investments
1.54B 1.42B 1.2B 1.16B 1.04B 831.87M 624.46M 414.19M 228.04M 164.91M 183.17M 189.19M 186.05M 190.11M 130.56M 88.06M 38.06M n/a
Other Investing Acitivies
-29.27M 6.39M n/a 43.14K 72.76K -6.66M -705.43K -783.38K -777.45K -414.64K 34.85K 95.65K -16.69M 21.35M -150.81M -150.83M -134.03M -172.09M
Investing Cash Flow
-1.27B -1.43B -2.01B -1.46B -523.13M -776.28M -773.31M -795.34M -782.91M -423.18M 74.58M 110.62M 57.44M 10.75M -212.31M -213.11M -194.62M -174.15M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1K
Common Stock Repurchased
5.53M 5.53M 5.53M 11.11M 5.58M 5.58M 5.58M n/a n/a n/a n/a n/a n/a n/a n/a 374K 374K 374K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -313K -313K -313K
Other Financial Acitivies
5.68M 6.99M 7.95M 10.69M 7.84M 5.69M 3.75M 4.03M 5.37M 4.56M 5.07M 4.02M 3.61M 3.69M 3.9M 2.49M 2.03M 265.56M
Financial Cash Flow
1.52B 1.63B 2.45B 2.45B 979.85M 1.42B 639.81M 1.29B 1.29B 792.09M 861.55M 213.67M 177.25M 128.33M 17.8M 9.6M 2.03M 265.56M
Net Cash Flow
-210.61M -263.34M -8.26M 506.37M -12.13M 231.29M -436.97M 266.96M 292.86M 178.71M 765.67M 166.36M 87.18M 2.8M -316.34M -284.13M -258.18M 45.02M
Free Cash Flow
-534.89M -600.01M -578.18M -622.63M -588.73M -482.56M -364.67M -245.16M -219.66M -199.12M -176.44M -162.55M -153.29M -144.12M -127.95M -86.96M -69.91M -48.25M